NeurAxis Inc. (NRXS)
NASDAQ: NRXS
· Real-Time Price · USD
2.57
0.05 (1.98%)
At close: Jun 17, 2025, 12:40 PM
1.98% (1D)
| Bid | 2.55 |
| Market Cap | 24.48M |
| Revenue (ttm) | 2.93M |
| Net Income (ttm) | -8.4M |
| EPS (ttm) | -1.23 |
| PE Ratio (ttm) | -2.09 |
| Forward PE | -10.36 |
| Analyst | Buy |
| Ask | 2.6 |
| Volume | 100,220 |
| Avg. Volume (20D) | 1,597,682 |
| Open | 2.65 |
| Previous Close | 2.52 |
| Day's Range | 2.48 - 2.65 |
| 52-Week Range | 1.33 - 6.20 |
| Beta | 4.21 |
About NRXS
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NRXS
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NRXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-19.8%
Neuraxis shares are trading lower. The company ann...
Unlock content with
Pro Subscription
4 weeks ago
+75.77%
Neuraxis shares are trading higher after the company announced it received FDA 510(K) clearance regarding IB-stim for the treatment of pediatric FAP associated with functional dyspepsia and FD related nausea symptoms.
